Bayesian sample size determination for a Phase III clinical trial with diluted treatment effect

Ying-Ying ZhangDepartment of Statistics and Actuarial Science, College of Mathematics and Statistics, Chongqing University, Chongqing, ChinaCorrespondence[email protected] [email protected]

http://orcid.org/0000-0002-6279-3662 View further author information

Naitee TingDepartment of Biostatistics and Data Sciences, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA

http://orcid.org/0000-0002-9168-297X View further author information

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Ying-Ying Zhang, Teng-Zhong Rong & Man-Man Li. (2022) Eight predictive powers with historical and interim data for futility and efficacy analysis. Statistical Theory and Related Fields 6:4, pages 277-298.
Read now

Ying-Ying Zhang, Teng-Zhong Rong & Man-Man Li. (2021) Analytical calculations of various powers assuming normality. Sequential Analysis 40:4, pages 518-541.
Read now

Ying-Ying Zhang & Naitee Ting. (2020) Sample Size Considerations for a Phase III Clinical Trial with Diluted Treatment Effect. Statistics in Biopharmaceutical Research 12:3, pages 311-321.
Read now

Articles from other publishers (3)

Li Zhang & Ying-Ying Zhang. (2022) The Bayesian Posterior and Marginal Densities of the Hierarchical Gamma–Gamma, Gamma–Inverse Gamma, Inverse Gamma–Gamma, and Inverse Gamma–Inverse Gamma Models with Conjugate Priors. Mathematics 10:21, pages 4005.
Crossref

Ying-Ying Zhang & Qian Ran. (2022) The Imprecision Issues of Four Powers and Eight Predictive Powers with Historical and Interim Data. Mathematics 10:20, pages 3898.
Crossref

Ying‐Ying Zhang, Teng‐Zhong Rong & Man‐Man Li. (2020) The contemplated average success probability for normally distributed models with an application to optimal sample sizes selection. Statistics in Medicine 39:23, pages 3173-3183.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Bayesian sample size determination for a Phase III clinical trial with diluted treatment effect

Articles from other publishers (3)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Bayesian sample size determination for a Phase III clinical trial with diluted treatment effect

Citations (6)

Read on this site (3)

Articles from other publishers (3)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date